|1.||Albertioni, Freidoun: 1 article (01/2010)|
|2.||Mirzaee, Saeedeh: 1 article (01/2010)|
|3.||Eriksson, Staffan: 1 article (01/2010)|
|4.||Clausen, Anders Ranegaard: 1 article (11/2009)|
|5.||Cros-Perrial, Emeline: 1 article (11/2009)|
|6.||Dumontet, Charles: 1 article (11/2009)|
|7.||Hébrard, Claire: 1 article (11/2009)|
|8.||Jordheim, Lars Petter: 1 article (11/2009)|
|9.||Piskur, Jure: 1 article (11/2009)|
|10.||Lutz, Stefan: 1 article (07/2007)|
11/01/2009 - "Transfer of deoxyribonucleoside kinases (dNKs) into cancer cells increases the activity of cytotoxic nucleoside analogues. "
11/01/1982 - "The importance of deoxynucleoside kinases, some of which may be cancer-induced, in obtaining selective anticancer effects is discussed. "
01/01/1994 - "Properties and levels of deoxynucleoside kinases in normal and tumor cells; implications for chemotherapy."
07/20/2007 - "In antiviral and cancer therapy, deoxyribonucleoside kinases (dNKs) are often the rate-limiting step in activating nucleoside analog (NA) prodrugs into their cytotoxic, phosphorylated forms. "
01/12/2010 - "Cytosolic and mitochondrial deoxynucleoside kinases (dNKs), as well as 5'deoxynucleotidases (5'-dNTs), control intracellular and intramitochondrial phosphorylation of natural nucleotides and nucleoside analogs used in antiviral and cancer chemotherapy. "
|1.||Drug Therapy (Chemotherapy)